skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


Title: Technoeconomic and Sustainability Analysis of Batch and Continuous Crystallization for Pharmaceutical Manufacturing
Continuous manufacturing in pharmaceutical industries has shown great promise to achieve process intensification. To better understand and justify such changes to the current status quo, a technoeconomic analysis of a continuous production must be conducted to serve as a predictive decision-making tool for manufacturers. This paper uses PharmaPy, a custom-made Python-based library developed for pharmaceutical flowsheet analysis, to simulate an annual production cycle for a given active pharmaceutical ingredient (API) of varying production volumes for a batch crystallization system and a continuous mixed suspension, mixed product removal (MSMPR) crystallizer. After each system is optimized, the generalized cost drivers, categorized as capital expenses (CAPEX) or operational expenses (OPEX), are compared. Then, a technoeconomic and sustainability cost analysis is done with the process mass intensity (PMI) as a green metric. The results indicate that while the batch system does have an overall lower cost and better PMI metric at smaller manufacturing scales in comparison with the continuous system, the latter system showed more potential for scaling-up for larger production volumes.  more » « less
Award ID(s):
2229250
PAR ID:
10549722
Author(s) / Creator(s):
;
Publisher / Repository:
Syst. Control Trans.
Date Published:
Volume:
3
Page Range / eLocation ID:
359 to 366
Format(s):
Medium: X
Location:
Breckenridge, Colorado, USA
Sponsoring Org:
National Science Foundation
More Like this
  1. ; ; ; ; ; (, Advances in Materials Science and Engineering)
    Kumar, Avvaru Praveen (Ed.)
    The pharmaceutical industry is looking for new and innovative ways of manufacturing to improve product quality and reduce process complexity. In manufacturing oral solid dosage products, blending is a crucial step in ensuring the homogeneity of active pharmaceutical ingredients (APIs) in the final product. Currently, batch and continuous blending are the two commonly used modes for blending in the industry. However, these methods have limitations in terms of blending time, manual intervention, and flexibility in handling multiple ingredients. To address these limitations, this study aims to explore the feasibility and benefits of using a semicontinuous blending mode in the pharmaceutical industry. A case study is conducted using a binary blend of microcrystalline cellulose and acetaminophen to compare the performance of the semicontinuous mode of blending with the batch and continuous blending modes. The results show that the semicontinuous blending setup can produce blends with good blend uniformity and homogeneity and that the output can be used for both batch and continuous downstream operations. The effect of variation in the three most important process parameters, impeller rotation per minute, blending time, and fill level on the blend uniformity, is also investigated. The semicontinuous blending mode had a higher line rate of 12.5 kg/hour than a similarly sized batch blender at 3.6 kg/hour and less than that of a continuous blender. The benefits of the new blending mode include reduced blending time, minimal manual intervention, flexibility in blending multiple ingredients, easier scale-up, and a smaller footprint. Overall, this study highlights the relative advantages of using this new semicontinuous blending mode in pharmaceutical manufacturing and its potential as a good alternative to the existing blending modes. The semicontinuous mode is well placed between the batch blending and continuous blending mode, with many benefits over the former mode and performance comparable to the latter continuous mode. 
    more » « less
  2. ; ; ; (, Biotechnology Progress)
    Abstract Continuous manufacturing platforms and membrane chromatography are process technologies with the potential to reduce production costs and minimize process variability in monoclonal antibody production. This study presents a simulation and optimization framework to perform techno‐economic analyses of these strategies. Multi‐objective optimization was used to compare batch and continuous multicolumn operating modes and membrane and resin process alternatives, revealing performance differences in productivity and cost of goods attributed to variations in dynamic binding capacity, media geometry, and process residence time. From the set of optimal process configurations, we selected one membrane and one resin platform alternative yielding the highest net present values to undergo sensitivity analyses involving variations in batch cadence and product selling price. For the scenarios considered in this work, membrane continuous platforms showed benefits in the cost of goods and process mass intensity. Their shorter residence time compared to resins positions them as a viable alternative for single‐use capture chromatography. Moreover, this low residence time makes membrane platforms more flexible to changes in throughput, an essential feature for integrating capture into fully continuous processes. 
    more » « less
  3. ; ; ; (, PSE Press)
    As pharmaceutical manufacturing is transitioning from traditional batch to continuous manufacturing (CM), there is a lack of tools for CM design and development, which can integrate drug substance and drug product unit operations for overall evaluation. Recently, a Python-based PharmaPy framework was proposed to advance the design, simulation, and analysis of continuous pharmaceutical processes. However, the initial library of models only addressed upstream drug substance processing. In this work, new capabilities, including drug product unit operations such as feeder, blender, and tablet press, have been added to the PharmaPy framework, enabling end-to-end study and optimizing the effects of material properties and process conditions on solid oral dosage products. The platform supports computational efficiency and model accuracy by allowing the development of different mechanistic and semi-mechanistic models. Sensitivity analysis is performed on the integrated end-to-end simulator to identify critical input variables influencing product quality and control strategies. The analysis lowers the complexity of the model by ranking significant input variables. Finally, feasibility studies are conducted on extracted influential input variables to characterize the process design space and achieve desirable output. The enhanced PharmaPy package can now support decision-making from early research and development stages through manufacturing. 
    more » « less
  4. ; ; ; ; (, Biomass Conversion and Biorefinery)
    The aim of this research was to evaluate the technoeconomic prospect of hydrochar production through co-hydrothermal carbonization of coal waste (CW) and food waste (FW). A process flow diagram was developed that considered seven reactors, six pumps, and other necessary equipment for producing 49,192 kg/h hydrochar. Three different cases were considered for the economic analysis. Case II considered both CW and FW transportation cost while cases I and III considered only FW and only CW transportation, respectively. The economic analysis revealed the break-even costs to be $62.24 per ton for case I, $69.90 per ton for case II, and $60.26 per ton for case III. The fixed capital investment (FCI) was $11.4M for all the cases while total capital investment (TCI), working capital (WC), and manufacturing costs were higher for case II compared to cases I and III. A sensitivity analysis examined the effect of nine different variables on the break-even cost. The raw materials’ cost as well as their transportation costs significantly affected the corresponding break-even cost. Additionally, increasing the hydrochar production capacity has drastically decreased the break-even cost. However, the analysis also revealed that excessive increase of production capacity can have negative impact on the process economics. 
    more » « less
  5. ; ; (, Reviews in Chemical Engineering)
    Abstract High-throughput and cost-efficient fabrication of intricate nanopatterns using top-down approaches remains a significant challenge. To overcome this limitation, advancements are required across various domains: patterning techniques, real-time and post-process metrology, data analysis, and, crucially, process control. We review recent progress in continuous, top-down nanomanufacturing, with a particular focus on data-driven process control strategies. We explore existing Machine Learning (ML)-based approaches for implementing key aspects of continuous process control, encompassing high-speed metrology balancing speed and resolution, modeling relationships between process parameters and yield, multimodal data fusion for comprehensive process monitoring, and control law development for real-time process adjustments. To assess the applicability of established control strategies in continuous settings, we compare roll-to-roll (R2R) manufacturing, a paradigmatic continuous multistage process, with the well-established batch-based semiconductor manufacturing. Finally, we outline promising future research directions for achieving high-quality, cost-effective, top-down nanomanufacturing and particularly R2R nanomanufacturing at scale. 
    more » « less
  • Citation Formats
  • MLA
  • APA
  • Chicago
  • BibTeX
  • Save / Share this Record
  • Send to Email